Log In Join Now
Forums  |  Help  |  Settings  |  Download
Research: Mapping Cancer Markers: Project News Collapse   Expand  
 
News 

RSS

Search Options
The news items shown only include the category and tags you've selected.

Tags
Award Behind the Scenes
Event or Milestone Media
Project Update Research Paper
Technical Issue Video
Website Update
Filter

Page: 1 2 Next Last >  


30 Nov 2017 – New Facility and Expanded Plans for the Mapping Cancer Markers Research Team
The Mapping Cancer Markers researchers recently moved to a new institute, but continues analyzing results, planning for expanded research, and creating new work units throughout the transition. Learn about their plans in this article.  
  Tags: Project Update

06 Apr 2017 – Mapping Cancer Markers Team Analyzes Lung Cancer Data
In this project update, the Mapping Cancer Markers team describes how they are analyzing 45 million of the most promising lung cancer data results, and how they have begun to disseminate their early findings.  
  Tags: Project Update

17 Oct 2016 – Mapping Cancer Markers Begins Analyzing Lung and Ovarian Cancer Data
The Mapping Cancer Markers researchers are analyzing the results of the lung cancer research tasks run on World Community Grid, as well as the first sets of ovarian cancer data. This update gives a detailed look at the tools and processes they are using for this analysis, plus a list of their recent publications and events in their lab.  
  Tags: Project Update

21 Apr 2016 – Mapping Cancer Markers Now Examining Ovarian Cancer
The Mapping Cancer Markers project now includes markers for the most common form of ovarian cancer, with a goal to understand the how this disease progresses from early-stage to late-stage.  
  Tags: Event or Milestone , Project Update

15 Dec 2015 – Working to detect lung and ovarian cancers before they start
Recent stages of the Mapping Cancer Markers (MCM) project have illuminated the protein-protein interactions and biological pathways involved in lung cancer, and have also suggested surprising results about its biomarkers. Once this current stage is complete, MCM will transition to analyzing ovarian cancer. Thanks to your help, we are making discoveries and helping the international research community. Dr. Jurisica, in particular, is one of the most frequently cited researchers worldwide.  
  Tags: Project Update

19 Aug 2015 –  One step closer to identifying lung cancer biomarkers
Although work continues, enough data has already been processed to let the Mapping Cancer Markers team begin identifying high-scoring signatures and associating them with particular lung cancer biomarkers. The ultimate goal is to find signatures that distinguish many types of cancer, giving physicians and researchers another tool to improve detection, treatment and patient outcomes.  
  Tags: Project Update

12 Feb 2015 – Using one cancer to help defeat many: Mapping Cancer Markers makes progress
Results from the first stage of the Mapping Cancer Markers project are helping the researchers identify the markers for lung cancer, as well as improve their research methodology as they move on to analyze other cancers.  
  Tags: Project Update

27 Oct 2014 – Early-stage results from the Mapping Cancer Markers team
Thanks to your help, the Mapping Cancer Markers team is nearly finished with benchmarking their first set of genetic markers. In this update, the team presents an in-depth review of what they've accomplished thus far, and what significance this early work will have for cancer research at their lab and elsewhere.  
  Tags: Project Update

02 Oct 2014 – Global PC network gives researchers supercomputer power
An article published in the Toronto Star featured Dr. Igor Jurisica, the lead researcher of the Mapping Cancer Markers project. He discussed the value of the supercomputing power that is provided to researchers through a global network of home and business computers.  
  Tags: Media

10 Jul 2014 – Project roadmap and first phase results from the Mapping Cancer Markers team
The lead researcher for Mapping Cancer Markers presents a roadmap for the project to analyze signatures for 4 types of cancer: lung, ovarian, prostate and sarcoma; an update on his team’s progress thus far, and an invitation to join the research team in an August cancer fundraiser.  
  Tags: Project Update

Return to Top